Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramFátima Cardoso, Sharon H. Giordano, Leen Slaets et al.|Annals of Oncology|2017Cited by 396
89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work upFrederike Bensch, C.P. Schröder|European Journal of Nuclear Medicine and Molecular Imaging|2018Cited by 137